The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial
No abstract is available for this record.
Bibliographic context
- Journal
- Neuroscience Applied
- Date
- 2025-12-31
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
psilocybin PharmacologyClinical TrialRandomized Controlled TrialToxicity Randomized Controlled Trial Randomized controlled trialMedicinePsilocybinPhase (matter)PharmacologyInternal medicineAnesthesiaClinical trialPlaceboMEDLINEPsychedelics and Drug StudiesForensic Toxicology and Drug AnalysisParanormal Experiences and Beliefs
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use DisorderPsychedelic Medicine · 2024-11-24Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27Psilocybin reporting in media (PRiMe) for the treatment of depressionIrish Journal of Psychological Medicine · 2025-12-17